Baudax Bio Inc (BXRXQ)

Baudax Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	5.26	15.89	30.34	17.74	0
Cash & Cash Equivalents	5.26	15.89	30.34	17.74	0
Cash Growth	-66.91%	-47.63%	71.04%	-	-
Receivables	0	0.54	0.05	0	0
Inventory	0	5	2.98	0	0
Other Current Assets	1.09	2.06	3.35	2.4	2.51
Total Current Assets	6.35	23.49	36.72	20.14	2.51
Property, Plant & Equipment	0.86	5.02	5.05	5.55	3.98
Goodwill and Intangibles	2.13	23.81	26.38	28.53	28.53
Other Long-Term Assets	0.7	0.96	0.58	0	0
Total Long-Term Assets	3.69	29.78	32.02	34.08	32.51
Total Assets	10.03	53.28	68.73	54.21	35.02
Accounts Payable	3.2	1.47	3.65	0.27	2.65
Current Debt	5.83	2.22	0.68	0.32	0
Other Current Liabilities	12.43	11.96	13.79	7.12	20.13
Total Current Liabilities	21.46	15.65	18.13	7.71	22.78
Long-Term Debt	2.1	6.31	8.47	0.46	0
Other Long-Term Liabilities	10.71	18.1	56.93	62.77	80.59
Total Long-Term Liabilities	12.81	24.41	65.4	63.22	80.59
Total Liabilities	34.27	40.05	83.53	70.93	103.37
Total Debt	7.94	8.53	9.15	0.77	0
Debt Growth	-6.99%	-6.79%	1083.96%	-	-
Retained Earnings	-190.9	-132.09	-112.32	-36.22	0
Shareholders' Equity	-24.24	13.23	-14.8	-16.72	-68.35
Net Cash / Debt	-2.68	7.36	21.19	16.97	0
Net Cash / Debt Growth	-	-65.27%	24.89%	-	-
Net Cash Per Share	-8.07	134.46	1591.32	2540.35	-
Working Capital	-15.11	7.85	18.59	12.42	-20.27
Book Value Per Share	-73.10	241.62	-1111.37	-2503.49	-10233.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).